Isomorphic Labs has created an AI drug design engine that reimagined traditional drug discovery approaches and allowed the company to go after some of the hardest disease targets. IsoLabs’ frontier AI research has yielded models that can accurately predict properties of proteins and other molecules and allow chemists to rationally design the next generation of medicines in-silico, in record time.